Breaking News Instant updates and real-time market news.

UMPQ

Umpqua Holdings

$20.52

-0.77 (-3.62%)

, BOFI

BofI Holding

$34.35

-0.78 (-2.22%)

04:55
02/09/18
02/09
04:55
02/09/18
04:55

Keefe Bruyette to hold a conference

Winter Financial Services Conference is being held in Doral, FL on February 8-9 with a kick-off dinner being held on February 7 at 7 pm.

UMPQ

Umpqua Holdings

$20.52

-0.77 (-3.62%)

BOFI

BofI Holding

$34.35

-0.78 (-2.22%)

ABCB

Ameris Bancorp

$51.60

-0.8 (-1.53%)

CNS

Cohen & Steers

$38.93

-0.48 (-1.22%)

CUBI

Customers Bancorp

$29.14

-0.89 (-2.96%)

FMBI

First Midwest

$24.03

-0.41 (-1.68%)

FULT

Fulton Financial

$17.75

-0.4 (-2.20%)

GHL

Greenhill & Co.

HLI

Houlihan Lokey

$46.06

-0.99 (-2.10%)

COLB

Columbia Banking

$40.81

-1.34 (-3.18%)

BANC

Banc of California

$19.35

-0.05 (-0.26%)

PACW

PacWest Bancorp

$50.31

-1.28 (-2.48%)

STBA

S&T Bancorp

$38.51

-0.83 (-2.11%)

PRK

Park National

$99.03

-2.14 (-2.12%)

LAZ

Lazard

$53.82

-2.91 (-5.13%)

STL

Sterling Bancorp

$22.65

-1.15 (-4.83%)

WAL

Western Alliance

$56.77

-2.14 (-3.63%)

WBS

Webster Financial

$52.54

-2.21 (-4.04%)

IBKC

Iberiabank

$78.85

-3.1 (-3.78%)

HOPE

Hope Bancorp

$17.49

-0.37 (-2.07%)

MC

Moelis

$52.00

2.25 (4.52%)

KFN

KKR Financial

BSX

Boston Scientific

$25.20

-1.12 (-4.26%)

  • 12

    Feb

  • 26

    Feb

  • 05

    Mar

  • 06

    Mar

  • 13

    Mar

  • 13

    Mar

  • 14

    Mar

  • 15

    Mar

  • 23

    Mar

UMPQ Umpqua Holdings
$20.52

-0.77 (-3.62%)

01/04/18
01/04/18
UPGRADE
Target $25

Outperform
Umpqua Holdings upgraded to Outperform at Wedbush
As previously reported, Wedbush analyst David Chiaverini upgraded Umpqua Holdings to Outperform from Neutral driven by his expectation that the company's Next Generation 2020 initiative should lead to faster earnings growth relative to peers, improving profitability metrics, and a much lower efficiency ratio as the company consolidates 1/3 of its store footprint. The analyst also raised his price target on the shares to $25 from $24.
01/04/18
WEDB
01/04/18
UPGRADE
WEDB
Outperform
Umpqua Holdings upgraded to Outperform from Neutral at Wedbush
11/08/17
KBWI
11/08/17
UPGRADE
Target $23
KBWI
Outperform
Umpqua upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Jacquelynne Bohlen upgraded Umpqua Holdings to Outperform and raised her price target for the shares to $23 from $22. The analyst is positive on the company's initiatives.
10/11/17
DADA
10/11/17
NO CHANGE
Target $68
DADA
Neutral
Bank of Marin has large exposure to California wildfire area, says DA Davidson
DA Davidson analysts Jeff Rulis and Gary Tenner say the Bank of Marin (BMRC) is among the regional banks with large exposure to wildfires in Northern California, with combined deposits in Napa and Sonoma counties accounting for nearly 23% of total bank deposits. DA Davidson conservatively estimates the bank's direct loans to the wine industry at about 5% of the total. They also highlighted SIVB Financial (SIVB) and Umpqua Holdings (UMPQ) as exposed.
BOFI BofI Holding
$34.35

-0.78 (-2.22%)

10/04/17
CHLM
10/04/17
NO CHANGE
Target $39
CHLM
Buy
Craig-Hallum recommends ignoring short noise, buying BofI Holding
Craig-Hallum analyst Brad Berning says he has obtained the letter from the SEC to BofI Holding dated June 28, 2017 concluding that there is no action to be taken against the company. The analyst recommends investors ignore the short noise and buy the stock. Berning thinks the company is on the verge of improving its loan growth after low rates pressured growth this past year. The analyst reiterates a Buy rating on the stock, while raised his price target on the shares to $39 from $35.
08/21/17
CHLM
08/21/17
NO CHANGE
CHLM
Vantiv, PayPal could be $100 stocks by 2020, says Craig-Hallum
Craig-Hallum analyst Brad Berning notes that PayPal (PYPL) and Vantiv (VNTV) are two different business models that are both winning market share within the global secular growth of payments converting to digital from cash and check. The analyst believes both companies could be $100 stocks by 2020. Berning is also adding Blackhawk (HAWK) to his near-term risk/reward list, removing Vantiv and keeping PayPal, LendingClub (LC) and BofI Holding (BOFI).
10/10/17
CHLM
10/10/17
NO CHANGE
CHLM
Green Dot, CPI Card added to Favorite Near-Term Risk/Reward List at Craig-Hallum
Craig-Hallum analyst Brad Berning added Green Dot (GDOT) and CPI Card Group (PMTS) to his Favorite Near-Term Risk/Reward List, saying he expects the former's positive momentum and estimate revisions to continue while believing the current quarter and 4Q outlook can be a positive catalyst for the latter. The analyst also sees positive near-term catalysts for Blackhawk (HAWK), LendingClub (LC), Verifone (PAY) and BofI Holding (BOFI).
10/09/17
KBWI
10/09/17
DOWNGRADE
Target $31
KBWI
Market Perform
BofI Holding resumed with a Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette resumed coverage of BofI Holding and downgraded the shares to Market Perform with a $31 price target.
ABCB Ameris Bancorp
$51.60

-0.8 (-1.53%)

11/20/17
KBWI
11/20/17
UPGRADE
Target $57
KBWI
Outperform
Ameris Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brady Gailey upgraded Ameris Bancorp to Outperform and raised his price target for the shares to $57 from $52 following the company's update on the Atlantic Coast Financial (ACFC) acquisition and Bank Secrecy Act compliance.
10/05/17
PIPR
10/05/17
INITIATION
Target $47.5
PIPR
Neutral
Ameris Bancorp assumed with a Neutral at Piper Jaffray
Piper Jaffray analyst William Curtiss assumed coverage of Ameris Bancorp with a Neutral rating and $47.50 price target.
09/28/17
SPHN
09/28/17
NO CHANGE
Target $52
SPHN
Overweight
Ameris Bancorp called 2017 Best Idea at Stephens
Stephens analyst Tyler Stafford has changed his 2017 Best Idea to Ameris Bancorp (ABCB) from CenterState Banks (CSFL), citing expectations for Ameris to see strong near-term outperformance following the likely resolution of its regulatory BSA order. Additionally, he expects Ameris to make a series of EPS and tangible book value accretive acquisitions. He reiterates his Overweight rating and $52 price target on Ameris shares.
01/29/18
RHCO
01/29/18
NO CHANGE
Target $65
RHCO
Buy
Ameris Bancorp price target raised to $65 from $59 at SunTrust
SunTrust analyst Jennifer Demba raised her price target on Ameris Bancorp to $65, saying the Hamilton State acquisition will allow the bank to grow through the $10 billion threshold's expense and revenue head winds. The analyst also expects the cash from lower U.S. tax rates to be earnings-accretive while helping fund future growth. Demba keeps her Buy rating on Ameris Bancorp.
CNS Cohen & Steers
$38.93

-0.48 (-1.22%)

01/11/18
GABE
01/11/18
DOWNGRADE
Target $54
GABE
Hold
Cohen & Steers downgraded to Hold from Buy at Gabelli
Gabelli analyst Macrae Sykes downgraded Cohen & Steers to Hold with a $54 PMV saying he expects momentum to moderate in 2018 due to continued negative pressure from parts of Japan distribution and slower sales of preferred products.
03/03/17
SIDC
03/03/17
INITIATION
Target $46
SIDC
Buy
Cohen & Steers initiated with a Buy at Sidoti
Sidoti analyst Eduardo Seda started Cohen & Steers with a Buy rating and $46 price target.
01/26/18
KBWI
01/26/18
DOWNGRADE
Target $38
KBWI
Underperform
Cohen & Steers downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Ann Dai downgraded Cohen & Steers to Underperform and lowered her price target for the shares to $38 from $49 following the company's Q4 results. The analyst believes Cohen & Steers' near-term trends will remain challenging.
CUBI Customers Bancorp
$29.14

-0.89 (-2.96%)

12/08/17
RILY
12/08/17
INITIATION
Target $35
RILY
Buy
Customers Bancorp resumed with a Buy at B. Riley FBR
B. Riley FBR resumed coverage of Customers Bancorp with a Buy rating and $35 price target.
10/20/17
BOSC
10/20/17
DOWNGRADE
BOSC
Neutral
Customers Bancorp downgraded to Neutral at Boenning & Scattergood
FMBI First Midwest
$24.03

-0.41 (-1.68%)

05/19/17
FIGP
05/19/17
UPGRADE
Target $26
FIGP
Outperform
First Midwest upgraded to Outperform from Market Perform at Fig Partners
Fig Partners upgraded First Midwest to Outperform with a $26 price target citing valuation.
07/24/17
PIPR
07/24/17
UPGRADE
Target $26
PIPR
Overweight
First Midwest upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Nathan Race upgraded First Midwest to Overweight and raised his price target for the shares to $26 from $25. The stock at current levels undervalues the bank's short duration loan portfolio and efficiency improvement from the acquisition of Standard Bancshares, the analyst contends.
07/27/17
FIGP
07/27/17
DOWNGRADE
FIGP
Market Perform
First Midwest downgraded to Market Perform from Outperform at Fig Partners
FULT Fulton Financial
$17.75

-0.4 (-2.20%)

07/13/17
SPHN
07/13/17
INITIATION
SPHN
Equal Weight
Fulton Financial initiated with an Equal Weight at Stephens
GHL Greenhill & Co.

08/21/17
UBSW
08/21/17
NO CHANGE
Target $9
UBSW
Sell
Greenhill & Co. price target lowered to $9 from $17 at UBS
UBS analyst Brennan Hawkin lowered his price target on Greenhill & Co. to $9 from $17 as he believes consensus estimates are at risk. The analyst lowered his estimates and noted the shares are trading at a premium to its group despite struggling to grow revenues, having a very weak pipeline, and a highly leveraged balance sheet which puts its dividend at risk. Hawkin reiterated his Sell rating on Greenhill & Co. shares.
10/10/17
SDLR
10/10/17
DOWNGRADE
SDLR
Hold
Greenhill & Co. downgraded to Hold from Buy at Sandler O'Neill
10/10/17
SDLR
10/10/17
DOWNGRADE
Target $18
SDLR
Hold
Greenhill downgraded to Hold ahead of Q3 results at Sandler O'Neill
Sandler O'Neill analyst Jeffery Harte downgraded Greenhill & Co. to Hold from Buy saying his estimates look optimistic after transaction announcements remained "disappointingly weak" for a third consecutive quarter. The analyst believes a "significant rebound" in transaction announcements will be necessary to support Greenhill's current share price. He cut his price target for the shares to $18 from $29.
06/02/17
KBWI
06/02/17
INITIATION
Target $22
KBWI
Market Perform
Greenhill & Co. assumed with a Market Perform at Keefe Bruyette
Target $22.
HLI Houlihan Lokey
$46.06

-0.99 (-2.10%)

05/11/17
05/11/17
DOWNGRADE
Target $38

Neutral
Houlihan Lokey downgraded to Neutral on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded Houlihan Lokey to Neutral from Buy and raised its price target to $38 from $36. Analyst Michael Needham downgraded shares citing valuation and slowing restructuring activity.
09/12/17
09/12/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DowDuPont (DWDP) initiated with an Outperform at Macquarie. 2. Bunge (BG) initiated with a Neutral at Baird. 3. Rite Aid (RAD) initiated with a Hold at Loop Capital. 4. Nike (NKE) was initiated with an Outperform at Bernstein, while Under Armour (UA) was initiated with an Underperform. 5. Houlihan Lokey (HLI) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/12/17
JPMS
09/12/17
INITIATION
Target $42
JPMS
Overweight
Houlihan Lokey initiated with an Overweight at JPMorgan
JPMorgan analyst Kenneth Worthington started Houlihan Lokey with an Overweight rating and $42 price target. The company's leadership position in its three businesses segments should drive pricing resiliency and better economics relative to peers, the analyst contends.
05/11/17
BOFA
05/11/17
DOWNGRADE
BOFA
Neutral
Houlihan Lokey downgraded to Neutral from Buy at BofA/Merrill
COLB Columbia Banking
$40.81

-1.34 (-3.18%)

10/17/17
DADA
10/17/17
NO CHANGE
Target $48
DADA
Buy
Columbia Banking price target raised to $48 from $45 at DA Davidson
DA Davidson analyst Jeff Rulis raised the price target on Columbia Banking System to $48 from $45, noting the regulatory approval of Pacific Continental deal has been ahead of schedule. Rulis says that integration and cost saving challenges remain, but he is confident that Columbia Banking can execute based on past transaction, maintaining a Buy rating on the stock.
07/31/17
PIPR
07/31/17
UPGRADE
Target $46
PIPR
Overweight
Columbia Banking upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Matthew Clark upgraded Columbia Banking System to Overweight and raised his price target for the shares to $46 from $43. The accelerating loan growth seen in Q2 should persist in Q3, Clark tells investors in a research note. He believes Columbia deserves a premium multiple as "one of the best core, funded C&I lenders in the industry."
03/16/17
DADA
03/16/17
UPGRADE
DADA
Buy
Columbia Banking upgraded at DA Davidson
As noted earlier, DA Davidson upgraded Columbia Banking (COLB) to Buy from Neutral. Analyst Jeff Rulis blames the decline in Columbia Banking's stock on investors' worries about its acquisition of Pacific Continental (PCBK) and the death of its CEO. However, the analyst says that Pacific Continental " is a high-quality franchise that is closely aligned with Columbia both strategically and culturally." He says that the deal "effectively leverages capital," and he thinks that the company still has a strong management team.and "one of the best-positioned deposit franchises" among stocks he covers. Target $45.
03/16/17
DADA
03/16/17
UPGRADE
Target $45
DADA
Buy
Columbia Banking upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Jeffrey Rulis upgraded Columbia Banking to Buy with a $45 price target.
BANC Banc of California
$19.35

-0.05 (-0.26%)

02/01/18
RILY
02/01/18
DOWNGRADE
Target $20
RILY
Neutral
Banc of California downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Stephen Moss downgraded Banc of California to Neutral and lowered his price target for the shares to $20 from $25. The analyst says expectations for better earnings results are delayed following the company's Q4 results.
05/04/17
KBWI
05/04/17
DOWNGRADE
Target $22
KBWI
Market Perform
Banc of California downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Jacquelynne Bohlen downgraded Banc of California to Market Perform with a $22 price target citing valuation following the company's Q1 results.
12/21/17
PIPR
12/21/17
INITIATION
Target $26
PIPR
Overweight
Banc of California initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Matthew Clark started Banc of California with an Overweight rating and $26 price target. The analyst believes the company's turnaround is making progress and sees upside to reset expectations with mid-double digit loan growth and net interest margin expansion.
01/26/18
FIGP
01/26/18
DOWNGRADE
FIGP
Underperform
Banc of California downgraded to Underperform from Market Perform at Fig Partners
PACW PacWest Bancorp
$50.31

-1.28 (-2.48%)

11/01/17
RAJA
11/01/17
DOWNGRADE
RAJA
Market Perform
PacWest Bancorp downgraded to Market Perform from Outperform at Raymond James
11/01/17
11/01/17
DOWNGRADE

Market Perform
PacWest Bancorp downgraded to Market Perform on NIM pressures at Raymond James
As previously reported, Raymond James downgraded PacWest (PACW) to Market Perform from Outperform. Analyst David Long believes consensus NIM expectations are overly bullish and reduced his estimates below consensus to reflect the company's loan mix shift and acquisition of CU Bancorp (CU). Long no longer expects near-term positive catalysts and believes Street estimates will be pressured until NIM expectations moderate.
01/19/18
DADA
01/19/18
NO CHANGE
Target $59
DADA
Buy
PacWest Bancorp price target raised to $59 from $53 at DA Davidson
DA Davidson analyst Gary Tenner raised his price target on PacWest Bancorp to $59 after Q4 earnings that showed a "solid loan production" and organic growth to reach $1.6B of new loans in 2017 - a high water mark for the year. Tenner adds that while sales will reset lower in Q1 on lower day count, they should grow again in Q2. The analyst keeps his Buy rating on PacWest Bancorp.
01/19/18
BMOC
01/19/18
NO CHANGE
Target $56
BMOC
Market Perform
PacWest Bancorp price target raised to $56 from $49 at BMO Capital
BMO Capital analyst Lana Chan raised her price target on PacWest Bancorp to $56 after Q4 earnings, attributing the miss to the sale of its loan portfolio assets and the write-down of VC loans. Chan contends however that the bank's core trends improved amid an annualized organic loan growth of 17%, as well as better than expected net interest margins and operating expenses. The analyst keeps her Market Perform rating on PacWest Bancorp.
STBA S&T Bancorp
$38.51

-0.83 (-2.11%)

PRK Park National
$99.03

-2.14 (-2.12%)

LAZ Lazard
$53.82

-2.91 (-5.13%)

01/08/18
GSCO
01/08/18
UPGRADE
Target $64
GSCO
Buy
Lazard upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Conor Fitzgerald upgraded Lazard to Buy and raised his price target for the shares to $64 from $50.
01/03/18
NOMU
01/03/18
UPGRADE
Target $62
NOMU
Buy
Lazard upgraded to Buy from Neutral at Nomura Instinet
Nomura Instinet analyst Steven Chubak upgraded Lazard to Buy and raised his price target for the shares to $62 from $46. The analyst sees "meaningful upside" given the company's exposure to large/cross-border deals that he believes are poised for a "meaningful recovery" in 2018.
01/08/18
GSCO
01/08/18
NO CHANGE
GSCO
Goldman bullish on Brokers into 2018, upgrades Lazard and Stifel
Goldman Sachs analyst Conor Fitzgerald remains bullish on the Brokers and financial service companies heading into 2018. The analyst thinks large-cap mergers and acquisitions could accelerate and financial deals could return. To reflect these trends, Fitzgerald upgraded both Lazard (LAZ) and Stifel Financial (SF) to Buy from Neutral. The analyst prefers E-Trade (ETFC) and Charles Schwab (SCHW) over TD Ameritrade (AMTD) on the belief that commission price cuts are more likely than not in 2018. Further, Fitzgerald views Interactive Brokers' valuation as full and downgraded the shares to Sell from Neutral. Lastly, he sees a more balanced risk/reward for MarketAxess (MKTX) in this low volatility environment and downgraded the shares to Neutral from Buy.
12/21/17
12/21/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PG&E (PCG) downgraded to Sector Perform from Outperform at RBC Capital with analyst Shelby Tucker stating that the company's "unexpected" decision to suspend its dividend suggests greater risk than he had assumed regarding the regulatory treatment of the California wildfires in October. 2. ConocoPhillips (COP) downgraded to Outperform from Focus List at Scotia Howard Weil. 3. Axovant Sciences (AXON) downgraded to Hold from Buy at Jefferies with analyst Michael Yee saying the company needs "more interesting" in-licensed compounds to renew investor interest in 2018 and to demonstrate the new CEO can drive shareholder value. 4. Lazard (LAZ) downgraded to Neutral from Buy at Buckingham with analyst James Mitchell saying he sees little operating leverage from the tax rate cut and said weakening restructuring revenues will be a drag on growth. 5. SunTrust (STI) downgraded to Neutral from Outperform at Wedbush with analyst Peter Winter citing valuation with the shares up 19% year-to-date. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
STL Sterling Bancorp
$22.65

-1.15 (-4.83%)

04/05/17
SPHN
04/05/17
INITIATION
Target $30
SPHN
Overweight
Sterling Bancorp initiated with an Overweight at Stephens
Stephens analyst Erik Zwick initiated Sterling Bancorp with an Overweight rating and $30 price target, citing its organic growth and M&A strategy.
04/11/17
04/11/17
INITIATION
Target $25

Market Perform
Sterling Bancorp initiated with a Market Perform at FBR Capital
FBR Capital analyst Stephen Moss started Sterling Bancorp with a Market Perform rating and $25 price target.
04/11/17
04/11/17
INITIATION
Target $25

Market Perform
Sterling Bancorp initiated with a Market Perform at FBR Capital
FBR Capital analyst Stephen Moss started Sterling Bancorp with a Market Perform rating and $25 price target.
11/20/17
JMPS
11/20/17
INITIATION
JMPS
Market Perform
Sterling Bancorp initiated with a Market Perform at JMP Securities
JMP Securities analyst Emlen Harmon started Sterling Bancorp with a Market Perform rating, saying he thinks the accretion targets for the combination with Astoria appear achievable, but deals can be "messy" initially and the stock is not as cheap.
WAL Western Alliance
$56.77

-2.14 (-3.63%)

10/23/17
DADA
10/23/17
NO CHANGE
Target $64
DADA
Buy
Western Alliance price target raised to $64 from $60 at DA Davidson
DA Davidson analyst Gary Tenner raised his price target on Western Alliance to $64 after Q3 results, saying the company is well-positioned to grow earnings while maintaining its strong profitability metrics. Tenner notes that he expects continued positive operating leverage along with some potential for bank or non-bank acquisitions adding to Western Alliance tailwinds, maintaining his Buy rating on the stock.
01/29/18
RBCM
01/29/18
NO CHANGE
Target $68
RBCM
Outperform
Western Alliance price target raised to $68 from $63 at RBC Capital
RBC Capital analyst Jon Arfstrom raised his price target on Western Alliance to $68 and kept his Outperform rating after "another good quarter" of "strong revenue, expense, and loan trends". The analyst adds that while deposit growth slowed in Q4, it should accelerate in 2018, saying the company remains a growth story with "strong return generation, positive operating leverage, and solid credit quality metrics".
01/29/18
WELS
01/29/18
UPGRADE
Target $72
WELS
Outperform
Western Alliance upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Timur Braziler upgraded Western Alliance Bancorporation to Outperform and raised his price target for the shares to $72 from $61. The company's Q4 results begin to demonstrate its advantages from operating in more specialized and less competitive lending verticals, Braziler tells investors in a research note. The analyst sees more upside in the stock.
01/09/18
WELS
01/09/18
NO CHANGE
Target $61
WELS
Market Perform
Western Alliance price target raised to $62 from $54 at Wells Fargo
Wells Fargo analyst Jared Shaw raised his price target for Western Alliance to $62 from $54 as he believes it is well positioned to outperform in the current operating environment. The analyst reiterates a Market Perform rating on the shares.
WBS Webster Financial
$52.54

-2.21 (-4.04%)

01/09/18
WELS
01/09/18
NO CHANGE
Target $60
WELS
Market Perform
Webster Financial price target raised to $60 from $55 at Wells Fargo
Wells Fargo analyst Jared Shaw raised his price target for Webster Financial to $60 from $55 to reflect tax reform. The analyst reiterates a Market Perform rating on the shares.
01/05/18
PIPR
01/05/18
UPGRADE
Target $55
PIPR
Neutral
Webster Financial upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst Matthew Breese upgraded Webster Financial to Neutral and raised his price target for the shares to $55 from $49.50. The analyst sees an improved earnings outlook as it relates to higher interest rates and tax reform.
11/09/17
MSCO
11/09/17
NO CHANGE
Target $47
MSCO
Underweight
Morgan Stanley says Webster Financial valuation unjustified, stays Underweight
Morgan Stanley analyst Ken A Zerbe said his key takeaway from Webster Financial's investor day was that the bank is "solid" with stable and consistent operating performance. However, given its peer-average EPS growth, he continues to think the stock's high valuation cannot be justified and he keeps an Underweight rating on the shares with a $47 price target.
06/28/17
WEDB
06/28/17
INITIATION
WEDB
Outperform
Webster Financial initiated with an Outperform at Wedbush
Wedbush analyst David J. Chiaverini started coverage of Webster Financial with a $60 price target and an Outperform rating. The analyst expects the company's HSA subsidiary to generate "extraordinary growth..for years to come."
IBKC Iberiabank
$78.85

-3.1 (-3.78%)

10/25/17
RHCO
10/25/17
NO CHANGE
Target $80
RHCO
Hold
Iberiabank price target lowered to $80 from $90 at SunTrust
SunTrust analyst Jennifer Demba lowered her price target on Iberiabank to $80 and kept her Hold rating following Q3 results. Demba says the announced acquisition of Gibraltar Private Bank is low risk in nature, but results may be noisy over the next few quarters and NYC expansion could generate some added expenses.
12/20/17
RAJA
12/20/17
DOWNGRADE
RAJA
Outperform
Iberiabank downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst Michael Rose downgrade Iberiabank to Outperform and lowered its price target to $88 from $98 following a softer than expected 2018 revenue outlook, implying notably lower pre-tax income versus his model.
11/28/17
RHCO
11/28/17
UPGRADE
Target $85
RHCO
Buy
Iberiabank upgraded to Buy at SunTrust on 'compelling valuation'
As reported earlier, SunTrust analyst Jennifer Demba upgraded Iberiabank to Buy from Hold and raised her price target to $85 from $80. Demba says that the management is now more focused on improving return-on-average-assets following a substantial Q3 earnings miss. The analyst adds that December's outlook for FY18 may include more cost saving plans while added storm provisioning provides additional credit cost cushion. Demba also notes "compelling valuation" for Iberiabank, which trades at 12.8-times FY18 EPS consensus versus a peer median of 15.1-times.
11/28/17
RHCO
11/28/17
UPGRADE
RHCO
Buy
Iberiabank upgraded to Buy from Hold at SunTrust
HOPE Hope Bancorp
$17.49

-0.37 (-2.07%)

06/28/17
WEDB
06/28/17
INITIATION
WEDB
Neutral
Hope Bancorp initiated with a Neutral at Wedbush
Wedbush analyst David J. Chiaverini started coverage of Hope with a $20 price target and a Neutral rating.
09/15/17
FIGP
09/15/17
DOWNGRADE
FIGP
Market Perform
Hope Bancorp downgraded to Market Perform from Outperform at Fig Partners
09/18/17
DADA
09/18/17
NO CHANGE
DADA
Hope Bancorp shares attractive after retreat, says DA Davidson
After Hope announced the termination of its merger with U&I, DA Davidson analyst Gary Tenner is disappointed by the news, as he thought that it would have enabled the bank to "lock up the Korean American banking market" in Seattle. Nonetheless, he says that the company's stock is "on sale" after it fell, and he expects the company's EPS to reach a positive turning point early next year. He keeps a $21 price target and a Buy rating on the shares.
11/02/17
RAJA
11/02/17
DOWNGRADE
RAJA
Market Perform
Hope Bancorp downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Donald Worthington downgraded Hope Bancorp to Market Perform based on valuation following recent share strength.
MC Moelis
$52.00

2.25 (4.52%)

05/05/17
KBWI
05/05/17
INITIATION
Target $39
KBWI
Market Perform
Moelis initiated with a Market Perform at Keefe Bruyette
Keefe Bruyette analyst Ann Daistarted Moelis with a Market Perform rating and $39 price target.
KFN KKR Financial

BSX Boston Scientific
$25.20

-1.12 (-4.26%)

01/05/18
RBCM
01/05/18
UPGRADE
RBCM
Top Pick
Boston Scientific upgraded to Top Pick from Outperform at RBC Capital
01/05/18
RBCM
01/05/18
UPGRADE
Target $31
RBCM
Top Pick
Boston Scientific upgraded to Top Pick at RBC Capital
As reported earlier, RBC Capital analyst Glenn Novarro upgraded Boston Scientific to Top Pick from Outperform, keeping his $31 price target. Novarro says the Q4 earnings expected out on February 1st will be a positive catalyst in addressing concerns around 2018 outlook in late November when the company announced another delay in its LOTUS Edge system.
01/09/18
LEER
01/09/18
NO CHANGE
LEER
Outperform
Boston Scientific should outperform on 'strong beat,' says Leerink
Leerink analyst Danielle Antalffy notes that Boston Scientific preannounced better than expected Q4 results. The analyst sees this quarterly performance as particularly encouraging, given the fact that Boston Scientific delivered outperformance across all business segments despite facing a tough comp. Antalffy expects the stock to outperform on this strong beat, and continues to believe Boston Scientific represents "one of the most attractive" top-line growth stories in large-cap MedTech. She reiterates an Outperform rating on the shares.
01/03/18
EVER
01/03/18
INITIATION
Target $27
EVER
In Line
Boston Scientific initiated with an In Line at Evercore ISI
Evercore ISI analyst Vijay Kumar started Boston Scientific with an In Line rating and $27 price target, stating that a lack of Lotus upside sets it up as a decelerating topline story.

TODAY'S FREE FLY STORIES

JKHY

Jack Henry

$121.95

1.79 (1.49%)

12:59
02/24/18
02/24
12:59
02/24/18
12:59
Conference/Events
Jack Henry management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

PFBC

Preferred Bank

$64.05

0.86 (1.36%)

12:52
02/24/18
02/24
12:52
02/24/18
12:52
Conference/Events
Preferred Bank management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 13

    Mar

  • 24

    Sep

R

Ryder

$74.54

0.19 (0.26%)

12:47
02/24/18
02/24
12:47
02/24/18
12:47
Conference/Events
Ryder management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

ASPU

Aspen Group

$8.85

1.48 (20.08%)

12:29
02/24/18
02/24
12:29
02/24/18
12:29
Conference/Events
Aspen Group to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

TWTR

Twitter

$32.66

0.55 (1.71%)

, AOBC

American Outdoor Brands

$10.00

-0.12 (-1.19%)

10:47
02/24/18
02/24
10:47
02/24/18
10:47
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

TWTR

Twitter

$32.66

0.55 (1.71%)

AOBC

American Outdoor Brands

$10.00

-0.12 (-1.19%)

RGR

Sturm, Ruger

$49.90

0.9 (1.84%)

X

U.S. Steel

$43.52

0.54 (1.26%)

STLD

Steel Dynamics

$47.47

-0.53 (-1.10%)

NUE

Nucor

$66.94

-0.01 (-0.01%)

AKS

AK Steel

$5.50

-0.12 (-2.14%)

AET

Aetna

$175.55

0.49 (0.28%)

ANTM

Anthem

$235.24

1.56 (0.67%)

CNC

Centene

$100.45

0.96 (0.96%)

CI

Cigna

$194.79

2.89 (1.51%)

HNT

Health Net

HUM

Humana

$271.19

3.38 (1.26%)

MOH

Molina Healthcare

$72.94

1.38 (1.93%)

UNH

UnitedHealth

$230.16

3.07 (1.35%)

WCG

WellCare

$192.05

0.03 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 01

    Mar

  • 07

    Mar

  • 13

    Mar

  • 16

    Apr

  • 30

    May

DBX

Dropbox

, SNAP

Snap

$17.45

-0.06 (-0.34%)

09:49
02/24/18
02/24
09:49
02/24/18
09:49
Periodicals
Dropbox IPO bodes well, Barron's says »

In a follow-up article…

DBX

Dropbox

SNAP

Snap

$17.45

-0.06 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

IPG

Interpublic Group

$24.24

0.3 (1.25%)

, OMC

Omnicom

$77.31

0.52 (0.68%)

09:42
02/24/18
02/24
09:42
02/24/18
09:42
Periodicals
Advertising companies cheaper than usual, Barron's says »

After a tumble last year,…

IPG

Interpublic Group

$24.24

0.3 (1.25%)

OMC

Omnicom

$77.31

0.52 (0.68%)

PUBGY

Publicis

$18.82

0.09 (0.48%)

WPP

WPP

$95.30

0.93 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 05

    Mar

MSFT

Microsoft

$94.06

2.33 (2.54%)

, INTC

Intel

$47.73

1.93 (4.21%)

09:36
02/24/18
02/24
09:36
02/24/18
09:36
Periodicals
Quantum computing soon to be reality, Barron's says »

Microsoft (MSFT) predicts…

MSFT

Microsoft

$94.06

2.33 (2.54%)

INTC

Intel

$47.73

1.93 (4.21%)

NVDA

Nvidia

$245.93

3.78 (1.56%)

MU

Micron

$46.53

2.28 (5.15%)

GOOG

Alphabet

$1,126.79

20.16 (1.82%)

GOOGL

Alphabet Class A

$1,128.09

18.19 (1.64%)

AMZN

Amazon.com

$1,500.00

14.66 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 28

    Feb

  • 07

    Mar

  • 07

    Mar

  • 13

    Mar

  • 14

    Mar

  • 18

    Mar

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 30

    May

AMZN

Amazon.com

$1,500.00

14.66 (0.99%)

09:26
02/24/18
02/24
09:26
02/24/18
09:26
Periodicals
Many downsides when Amazon's HQ2 comes to town, Barron's says »

As Amazon decides on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 18

    Mar

BHGE

Baker Hughes

$28.03

-0.01 (-0.04%)

04:55
02/24/18
02/24
04:55
02/24/18
04:55
Conference/Events
Baker Hughes management to meet with UBS »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

GE

General Electric

$14.49

-0.01 (-0.07%)

18:49
02/23/18
02/23
18:49
02/23/18
18:49
Periodicals
General Electric could face DOJ action over subprime mortgages, Reuters says »

General Electric may face…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEDU

Bright Scholar

$20.15

0.34 (1.72%)

18:30
02/23/18
02/23
18:30
02/23/18
18:30
Syndicate
Bright Scholar files to sell 10M American Depositary Shares »

Each ADS represents one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.02

2.11 (1.62%)

, CMD

Cantel Medical

$115.34

2.45 (2.17%)

18:03
02/23/18
02/23
18:03
02/23/18
18:03
Periodicals
J&J sterilization unit draws bids from Cantel Medical, Medtronic, Bloomberg says »

Cantel Medical (CMD) and…

JNJ

Johnson & Johnson

$132.02

2.11 (1.62%)

CMD

Cantel Medical

$115.34

2.45 (2.17%)

MDT

Medtronic

$80.39

-0.02 (-0.02%)

KKR

KKR

$21.96

0.18 (0.83%)

CG

Carlyle Group

$23.15

-0.1 (-0.43%)

MMM

3M

$237.02

1.02 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 08

    Mar

  • 14

    Mar

  • 23

    Mar

  • 23

    Apr

  • 30

    May

AET

Aetna

$175.55

0.49 (0.28%)

, CVS

CVS Health

$68.16

0.16 (0.24%)

18:00
02/23/18
02/23
18:00
02/23/18
18:00
Hot Stocks
Aetna: CVS deal part of long-term solution toward value-based system »

According to prepared…

AET

Aetna

$175.55

0.49 (0.28%)

CVS

CVS Health

$68.16

0.16 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 30

    May

MYND

MYnd Analytics

$2.60

0.0301 (1.17%)

17:56
02/23/18
02/23
17:56
02/23/18
17:56
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$2.60

0.0301 (1.17%)

17:55
02/23/18
02/23
17:55
02/23/18
17:55
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRV

ContraVir Pharmaceuticals

$0.27

0.0027 (1.02%)

17:43
02/23/18
02/23
17:43
02/23/18
17:43
Hot Stocks
Gabriele Cerrone reports 7.0% stake in ContraVir Pharma, may seek board changes »

The shares of common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$40.98

0.09 (0.22%)

17:41
02/23/18
02/23
17:41
02/23/18
17:41
Periodicals
VW settles U.S. diesel suit just before trial, Reuters reports »

Volkswagen's U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAC

IAC

$153.99

3.2 (2.12%)

17:40
02/23/18
02/23
17:40
02/23/18
17:40
Hot Stocks
Breaking Hot Stocks news story on IAC »

Barry Diller reports 8.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SPG

Simon Property

$156.66

2.63 (1.71%)

17:37
02/23/18
02/23
17:37
02/23/18
17:37
Syndicate
Breaking Syndicate news story on Simon Property »

Simon Property files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

$28.64

0.99 (3.58%)

17:35
02/23/18
02/23
17:35
02/23/18
17:35
Hot Stocks
Fabrinet director Frank Levinson buys 10,000 shares of company stock »

Frank Levinson, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 12

    Mar

  • 29

    Mar

CASI

Casi Pharmaceuticals

$3.85

0.1 (2.67%)

17:33
02/23/18
02/23
17:33
02/23/18
17:33
Syndicate
Breaking Syndicate news story on Casi Pharmaceuticals »

Casi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

Dexcom

$56.36

-0.04 (-0.07%)

, TNDM

TNDM

17:31
02/23/18
02/23
17:31
02/23/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Dexcom, TNDM »

DexCom reports 5.6%…

DXCM

Dexcom

$56.36

-0.04 (-0.07%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 01

    Mar

  • 04

    Mar

IDXX

Idexx Laboratories

$187.61

3.75 (2.04%)

17:24
02/23/18
02/23
17:24
02/23/18
17:24
Hot Stocks
Idexx Laboratories director sells 4,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 04

    Mar

CYDY

CytoDyn

$0.72

0.02 (2.86%)

17:23
02/23/18
02/23
17:23
02/23/18
17:23
Syndicate
Breaking Syndicate news story on CytoDyn »

CytoDyn files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.